Hizentra SmPC

All other products are registered trademarks of their respective companies. For medical enquiries: MEAmedicalinfo@cslbehring.com
We routinely monitor the safety of our medications. If you want to report an adverse reaction with any of our products, please contact us at MEA: PhV-ECI@cslbehring.com Saudi Arabia: PhVSA@cslbehring.com United Arab Emirates: PV-UAE@cslbehring.com
CSL Behring Middle East & Africa: Dubai Science Park North Tower, Floor 9 HQ Complex, Offices 903-906, P.O. box: 478878, United Arab Emirates.
CSL Behring is a company of CSL Limited
www.CSLBehring.ae

Reporting of suspected adverse reactions
Saudi Arabia:
The National Pharmacovigilance Centre (NPC): SFDA Call Center: 19999
E-mail: npc.drug@sfda.gov.sa, Website: https://ade.sfda.gov.sa
United Arab Emirates:
Emirates Drug Establishment United Arab Emirates
Email: pv@ede.gov.ae, Tel: 80033784